News | February 23, 2022
GSK introduces Haleon to the world
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Appoints Dr Rafiq Hasan as CEO
he financing was significantly oversubscribed with high demand from both existing and new investors.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
The facility will manufacture its Herceptin biosimilar, Tuznue
New inhalers would have near-zero Global Warming Potential propellant
Subscribe To Our Newsletter & Stay Updated
